N,2,3-Trimethyl-N-(2-((4-methyl-3-sulfamoylphenyl)amino)pyrimidin-4-yl)-2H-indazol-6-amine oxide is an impurity of Pazopanib (P210925) which is an oral angiogenesis inhibitor targeting VEGFR and PDGFR.
Information
This product is for commercial use only and strictly NOT for human or animal consumption